AEZS Shares Outstanding History
Below is a table of the AEZS shares outstanding history going back to 12/31/2016:

Date AEZS Shares Outstanding

Also see: AEZS Market Cap History
AEZS Historical Shares Outstanding:
+15.67% CAGR
AEZS Historical Shares Outstanding: +15.67% CAGR

Mouse over chart for data details
12/31/2016 ...12/31/2019
AEterna Zentaris is a biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. Co.'s lead product, Macrilen™ (macimorelin) is an oral test indicated for the diagnosis of patients with adult growth hormone deficiency. Macrilen™ is marketed in the United States through a license and assignment agreement with Novo Nordisk A/S. Co. is also pursuing the development of macimorelin for the diagnosis of child-onset growth hormone deficiency. Co.'s principal focus is on the commercialization of Macrilen™ and it does not have any other approved products. We show 4 historical shares outstanding datapoints in our coverage of AEZS's shares outstanding history.

Understanding the changing numbers of AEZS shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like AEZS versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching AEZS by allowing them to research AEZS shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for AEZS:
AEZS SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
AEterna Zentaris (AEZS) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

AGEN Shares Outstanding History
AGIO Shares Outstanding History
AGLE Shares Outstanding History
AGN Shares Outstanding History
AGRX Shares Outstanding History
AGTC Shares Outstanding History
AHPI Shares Outstanding History
AIMT Shares Outstanding History
AIQ Shares Outstanding History
AKAO Shares Outstanding History
More Healthcare companies »


AEZS Shares Outstanding History | | Copyright © 2017 - 2021, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.